Phenotyping the pathophysiology of obstructive sleep apnea using polygraphy/polysomnography: a review of the literature

Marcello Bosi, Andrea De Vito, Bhik Kotecha, Luca Viglietta, Alberto Braghiroli, Joerg Steier, Martino Pengo, Giovanni Sorrenti, Riccardo Gobbi, Claudio Vicini, Venerino Poletti

Research output: Contribution to journalReview article

Abstract

Continuous positive airway pressure (CPAP) is the first-line treatment for the majority of patients affected by obstructive sleep apnea syndrome (OSA). However, long-term compliance with CPAP therapy may result limited and alternatives to CPAP therapy are required to address the increasing need to provide tailored therapeutic options. Understanding the pathophysiological traits (PTs) of OSA patients [upper airway (UA) anatomical collapsibility, loop gain (LG), arousal threshold (AT), and UA gain (UAG)] lies at the heart of the customized OSA treatment. However, sleep research laboratories capable to phenotype OSA patients are sparse and the diagnostic procedures time-consuming, costly, and requiring significant expertise. The question arises whether the use of routine clinical polysomnography or nocturnal portable multi-channel monitoring (PSG/PM) can provide sufficient information to characterize the above traits. The aim of the present review is to deduce if the information obtainable from the clinical PSG/PM analysis, independently of the scope and context of the original studies, is clinically useful to define qualitatively the PTs of individual OSA patients. In summary, it is possible to identify four patterns using PSG/PM that are consistent with an altered UA collapsibility, three that are consistent with altered LG, two with altered AT, and three consistent with flow limitation/UA muscle response. Furthermore, some PSG/PM indexes and patterns, useful for the suitable management of OSA patient, have been discussed. The delivery of this clinical approach to phenotype pathophysiological traits will allow patients to benefit in a wider range of sleep services by facilitating tailored therapeutic options.

Original languageEnglish
Pages (from-to)579-592
Number of pages14
JournalSleep and Breathing
Volume22
Issue number3
DOIs
Publication statusPublished - Sep 2018

Fingerprint

Polysomnography
Obstructive Sleep Apnea
Continuous Positive Airway Pressure
Arousal
Sleep
Therapeutics
Phenotype
Muscles
Research

Cite this

Phenotyping the pathophysiology of obstructive sleep apnea using polygraphy/polysomnography : a review of the literature. / Bosi, Marcello; De Vito, Andrea; Kotecha, Bhik; Viglietta, Luca; Braghiroli, Alberto; Steier, Joerg; Pengo, Martino; Sorrenti, Giovanni; Gobbi, Riccardo; Vicini, Claudio; Poletti, Venerino.

In: Sleep and Breathing, Vol. 22, No. 3, 09.2018, p. 579-592.

Research output: Contribution to journalReview article

Bosi, M, De Vito, A, Kotecha, B, Viglietta, L, Braghiroli, A, Steier, J, Pengo, M, Sorrenti, G, Gobbi, R, Vicini, C & Poletti, V 2018, 'Phenotyping the pathophysiology of obstructive sleep apnea using polygraphy/polysomnography: a review of the literature', Sleep and Breathing, vol. 22, no. 3, pp. 579-592. https://doi.org/10.1007/s11325-017-1613-3
Bosi, Marcello ; De Vito, Andrea ; Kotecha, Bhik ; Viglietta, Luca ; Braghiroli, Alberto ; Steier, Joerg ; Pengo, Martino ; Sorrenti, Giovanni ; Gobbi, Riccardo ; Vicini, Claudio ; Poletti, Venerino. / Phenotyping the pathophysiology of obstructive sleep apnea using polygraphy/polysomnography : a review of the literature. In: Sleep and Breathing. 2018 ; Vol. 22, No. 3. pp. 579-592.
@article{10eeff956c7844b8a0e3a36537ef2405,
title = "Phenotyping the pathophysiology of obstructive sleep apnea using polygraphy/polysomnography: a review of the literature",
abstract = "Continuous positive airway pressure (CPAP) is the first-line treatment for the majority of patients affected by obstructive sleep apnea syndrome (OSA). However, long-term compliance with CPAP therapy may result limited and alternatives to CPAP therapy are required to address the increasing need to provide tailored therapeutic options. Understanding the pathophysiological traits (PTs) of OSA patients [upper airway (UA) anatomical collapsibility, loop gain (LG), arousal threshold (AT), and UA gain (UAG)] lies at the heart of the customized OSA treatment. However, sleep research laboratories capable to phenotype OSA patients are sparse and the diagnostic procedures time-consuming, costly, and requiring significant expertise. The question arises whether the use of routine clinical polysomnography or nocturnal portable multi-channel monitoring (PSG/PM) can provide sufficient information to characterize the above traits. The aim of the present review is to deduce if the information obtainable from the clinical PSG/PM analysis, independently of the scope and context of the original studies, is clinically useful to define qualitatively the PTs of individual OSA patients. In summary, it is possible to identify four patterns using PSG/PM that are consistent with an altered UA collapsibility, three that are consistent with altered LG, two with altered AT, and three consistent with flow limitation/UA muscle response. Furthermore, some PSG/PM indexes and patterns, useful for the suitable management of OSA patient, have been discussed. The delivery of this clinical approach to phenotype pathophysiological traits will allow patients to benefit in a wider range of sleep services by facilitating tailored therapeutic options.",
author = "Marcello Bosi and {De Vito}, Andrea and Bhik Kotecha and Luca Viglietta and Alberto Braghiroli and Joerg Steier and Martino Pengo and Giovanni Sorrenti and Riccardo Gobbi and Claudio Vicini and Venerino Poletti",
year = "2018",
month = "9",
doi = "10.1007/s11325-017-1613-3",
language = "English",
volume = "22",
pages = "579--592",
journal = "Sleep and Breathing",
issn = "1520-9512",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Phenotyping the pathophysiology of obstructive sleep apnea using polygraphy/polysomnography

T2 - a review of the literature

AU - Bosi, Marcello

AU - De Vito, Andrea

AU - Kotecha, Bhik

AU - Viglietta, Luca

AU - Braghiroli, Alberto

AU - Steier, Joerg

AU - Pengo, Martino

AU - Sorrenti, Giovanni

AU - Gobbi, Riccardo

AU - Vicini, Claudio

AU - Poletti, Venerino

PY - 2018/9

Y1 - 2018/9

N2 - Continuous positive airway pressure (CPAP) is the first-line treatment for the majority of patients affected by obstructive sleep apnea syndrome (OSA). However, long-term compliance with CPAP therapy may result limited and alternatives to CPAP therapy are required to address the increasing need to provide tailored therapeutic options. Understanding the pathophysiological traits (PTs) of OSA patients [upper airway (UA) anatomical collapsibility, loop gain (LG), arousal threshold (AT), and UA gain (UAG)] lies at the heart of the customized OSA treatment. However, sleep research laboratories capable to phenotype OSA patients are sparse and the diagnostic procedures time-consuming, costly, and requiring significant expertise. The question arises whether the use of routine clinical polysomnography or nocturnal portable multi-channel monitoring (PSG/PM) can provide sufficient information to characterize the above traits. The aim of the present review is to deduce if the information obtainable from the clinical PSG/PM analysis, independently of the scope and context of the original studies, is clinically useful to define qualitatively the PTs of individual OSA patients. In summary, it is possible to identify four patterns using PSG/PM that are consistent with an altered UA collapsibility, three that are consistent with altered LG, two with altered AT, and three consistent with flow limitation/UA muscle response. Furthermore, some PSG/PM indexes and patterns, useful for the suitable management of OSA patient, have been discussed. The delivery of this clinical approach to phenotype pathophysiological traits will allow patients to benefit in a wider range of sleep services by facilitating tailored therapeutic options.

AB - Continuous positive airway pressure (CPAP) is the first-line treatment for the majority of patients affected by obstructive sleep apnea syndrome (OSA). However, long-term compliance with CPAP therapy may result limited and alternatives to CPAP therapy are required to address the increasing need to provide tailored therapeutic options. Understanding the pathophysiological traits (PTs) of OSA patients [upper airway (UA) anatomical collapsibility, loop gain (LG), arousal threshold (AT), and UA gain (UAG)] lies at the heart of the customized OSA treatment. However, sleep research laboratories capable to phenotype OSA patients are sparse and the diagnostic procedures time-consuming, costly, and requiring significant expertise. The question arises whether the use of routine clinical polysomnography or nocturnal portable multi-channel monitoring (PSG/PM) can provide sufficient information to characterize the above traits. The aim of the present review is to deduce if the information obtainable from the clinical PSG/PM analysis, independently of the scope and context of the original studies, is clinically useful to define qualitatively the PTs of individual OSA patients. In summary, it is possible to identify four patterns using PSG/PM that are consistent with an altered UA collapsibility, three that are consistent with altered LG, two with altered AT, and three consistent with flow limitation/UA muscle response. Furthermore, some PSG/PM indexes and patterns, useful for the suitable management of OSA patient, have been discussed. The delivery of this clinical approach to phenotype pathophysiological traits will allow patients to benefit in a wider range of sleep services by facilitating tailored therapeutic options.

U2 - 10.1007/s11325-017-1613-3

DO - 10.1007/s11325-017-1613-3

M3 - Review article

C2 - 29318567

VL - 22

SP - 579

EP - 592

JO - Sleep and Breathing

JF - Sleep and Breathing

SN - 1520-9512

IS - 3

ER -